Clinical Trials Directory

Trials / Completed

CompletedNCT03964402

Sample Size for Multivariate Time-to-event Data

Sample Size Determination in Heterogeneous Populations for Multivariate Time-to-event Data

Status
Completed
Phase
Study type
Observational
Enrollment
500 (actual)
Sponsor
Institut Bergonié · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

Most of randomized clinical trials (RCT) using time-to-event criteria as the primary endpoint are designed, powered and analyzed based on an hypothetical hazard ratio (HR) corresponding to the targeted effect size between experimental and control arms. Usually, one assumes that populations are homogeneous within each treatment arm, that is, within each arm, (i) the baseline risk is identical for all patients, and (ii) the treatment effect is identical for all patients. This assumption however may not hold in all circumstances. This project aims at providing a statistical method for the estimation of sample size in RCT, in the presence of heterogenous populations, such as assuming populations with distinct underlying baseline risks or assuming different treatment effects.

Conditions

Timeline

Start date
2019-01-01
Primary completion
2024-12-31
Completion
2024-12-31
First posted
2019-05-28
Last updated
2025-09-17

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT03964402. Inclusion in this directory is not an endorsement.

Sample Size for Multivariate Time-to-event Data (NCT03964402) · Clinical Trials Directory